Quipt Home Medical Corp.
QIPTNASDAQHealthcare
$3.65
+$0.00(+0.00%)
Market Cap$162297148
P/E Ratio—
52W High$3.65
52W Low$1.35
Quipt Home Medical Corp. (QIPT) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
QIPT · earnings · updated Jun 9, 2026
Latest Earnings
Q1 FY2026Report Date: Feb 10, 2026EPS Actual
-$0.02
Est. -$0.10 · +80.0%
Revenue
$0.08B
Est. $0.08B · +0.0%
Fiscal Period
Q1 FY2026
FY ends December
Report Date
Feb 10, 2026
After Market Close
▲ Beat EPS✓ 1-Quarter EPS Beat Streak
QIPT reports quarterly as a NASDAQ-listed Medical - Devices company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$93.32
Rev. $1001.5B
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$93.32
Rev. Est.$1001.5B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ▲ Q1 FY2026 | Feb 10, 2026 | -$0.10 | -$0.02 | +80.0% | $0.08B | $0.08B | +0.0% |
| ▼ Q4 FY2025 | Dec 15, 2025 | -$0.03 | -$0.08 | -152.6% | $0.07B | $0.11B | -35.7% |
| ▼ Q3 FY2025 | Aug 11, 2025 | -$0.07 | -$0.07 | -2.1% | $0.04B | $0.09B | -51.3% |
| ▼ Q2 FY2025 | May 12, 2025 | $0.02 | -$0.07 | -450.0% | $0.04B | $0.09B | -54.6% |
| ▲ Q1 FY2025 | Feb 10, 2025 | -$0.04 | -$0.03 | +25.0% | $0.04B | $0.09B | -51.9% |
| ▼ Q4 FY2024 | Dec 16, 2024 | -$0.02 | -$0.07 | -250.0% | $0.04B | $0.09B | -56.5% |
| ▼ Q3 FY2024 | Aug 14, 2024 | -$0.01 | -$0.04 | -166.7% | $0.05B | $0.07B | -28.4% |
| ▼ Q2 FY2024 | May 15, 2024 | -$0.00 | -$0.03 | -549.4% | $0.05B | $0.07B | -32.5% |
Q1 FY2026
Feb 10, 2026Beat
EPS Actual
-$0.02
EPS Est.
-$0.10
EPS Surpr.
+80.0%
Revenue
$0.08B
Q4 FY2025
Dec 15, 2025Miss
EPS Actual
-$0.08
EPS Est.
-$0.03
EPS Surpr.
-152.6%
Revenue
$0.07B
Q3 FY2025
Aug 11, 2025Miss
EPS Actual
-$0.07
EPS Est.
-$0.07
EPS Surpr.
-2.1%
Revenue
$0.04B
Q2 FY2025
May 12, 2025Miss
EPS Actual
-$0.07
EPS Est.
$0.02
EPS Surpr.
-450.0%
Revenue
$0.04B
Q1 FY2025
Feb 10, 2025Beat
EPS Actual
-$0.03
EPS Est.
-$0.04
EPS Surpr.
+25.0%
Revenue
$0.04B
Q4 FY2024
Dec 16, 2024Miss
EPS Actual
-$0.07
EPS Est.
-$0.02
EPS Surpr.
-250.0%
Revenue
$0.04B
Q3 FY2024
Aug 14, 2024Miss
EPS Actual
-$0.04
EPS Est.
-$0.01
EPS Surpr.
-166.7%
Revenue
$0.05B
Q2 FY2024
May 15, 2024Miss
EPS Actual
-$0.03
EPS Est.
-$0.00
EPS Surpr.
-549.4%
Revenue
$0.05B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2026 | $-0.10 | $-0.10 | $-0.10 | 1 |
| Q2 FY2026 | $-0.11 | $-0.11 | $-0.11 | 1 |
| Q1 FY2026 | $-0.13 | $-0.13 | $-0.13 | 1 |
| Q4 FY2025 | $-0.10 | $-0.10 | $-0.10 | 1 |
| Q3 FY2025 | $-0.03 | $-0.03 | $-0.03 | 1 |
| Q2 FY2025 | $-0.07 | $-0.07 | $-0.07 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2026 | $0.1B | $0.1B | $0.1B | 1 |
| Q2 FY2026 | $0.1B | $0.1B | $0.1B | 1 |
| Q1 FY2026 | $0.1B | $0.1B | $0.1B | 1 |
| Q4 FY2025 | $0.1B | $0.1B | $0.1B | 1 |
| Q3 FY2025 | $0.1B | $0.1B | $0.1B | 2 |
| Q2 FY2025 | $0.1B | $0.1B | $0.1B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q1 FY2026 | Feb 10, 2026 | +80.0% | $3.56 | $3.56 | +0.00% |
| ▼ Q4 FY2025 | Dec 15, 2025 | -152.6% | $2.61 | $3.50 | +34.10% |
| ▼ Q3 FY2025 | Aug 11, 2025 | -2.1% | $2.13 | $2.12 | -0.47% |
| ▼ Q2 FY2025 | May 12, 2025 | -450.0% | $2.18 | $2.13 | -2.29% |
| ▲ Q1 FY2025 | Feb 10, 2025 | +25.0% | $2.97 | $3.02 | +1.68% |
| ▼ Q4 FY2024 | Dec 16, 2024 | -250.0% | $3.01 | $3.07 | +1.99% |
| ▼ Q3 FY2024 | Aug 14, 2024 | -166.7% | $3.28 | $3.34 | +1.83% |
| ▼ Q2 FY2024 | May 15, 2024 | -549.4% | $4.04 | $3.97 | -1.73% |
Q1 FY2026+0.00%
Report Date
Feb 10, 2026
EPS Beat/Miss
+80.0%
Price Before
$3.56
Price After
$3.56
Q4 FY2025+34.10%
Report Date
Dec 15, 2025
EPS Beat/Miss
-152.6%
Price Before
$2.61
Price After
$3.50
Q3 FY2025-0.47%
Report Date
Aug 11, 2025
EPS Beat/Miss
-2.1%
Price Before
$2.13
Price After
$2.12
Q2 FY2025-2.29%
Report Date
May 12, 2025
EPS Beat/Miss
-450.0%
Price Before
$2.18
Price After
$2.13
Q1 FY2025+1.68%
Report Date
Feb 10, 2025
EPS Beat/Miss
+25.0%
Price Before
$2.97
Price After
$3.02
Q4 FY2024+1.99%
Report Date
Dec 16, 2024
EPS Beat/Miss
-250.0%
Price Before
$3.01
Price After
$3.07
Q3 FY2024+1.83%
Report Date
Aug 14, 2024
EPS Beat/Miss
-166.7%
Price Before
$3.28
Price After
$3.34
Q2 FY2024-1.73%
Report Date
May 15, 2024
EPS Beat/Miss
-549.4%
Price Before
$4.04
Price After
$3.97
Avg Beat Reaction+0.84%
Avg Miss Reaction+5.57%
Beat Rate2 / 8 quarters
Largest Move+34.10% (Q4 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: QIPT ends December
Quipt Home Medical Corp. (QIPT) most recently reported earnings on February 10, 2026 for Q1 FY2026, posting EPS of $-0.02 — beating the analyst consensus of $-0.10 by +80.0%. The next QIPT earnings date is expected around September 1, 2026.
Each quarter, investors track QIPT earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. QIPT revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
QIPT's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
QIPT earnings · 5 questionsQuipt Home Medical Corp.'s next earnings report is expected around September 1, 2026. QIPT typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; QIPT historically reports after market close (AMC).
QIPT earnings datewhen is QIPT earningsQIPT next earnings datewhen does QIPT report earningsQIPT earnings calendar
▸ Source: FMP · Quipt Home Medical Corp. SEC filings · US GAAP · Quipt Home Medical Corp. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026